Stock Market Briefing — April 15, 2026
The IMF has downgraded global growth projections for April 2026, putting focus on how this might impact the local economy. Meanwhile, a Citi report suggests the central bank could hike interest rates in July, with inflation expected to hover between 2.8% and 3.3% through September. On the bright side, the top 1,000 listed companies saw their operating profits near 190 trillion won last year—a record high since 2000.
Stock Market Briefing — April 15, 2026
Macroeconomic and Policy Trends
IMF Downgrades Global Growth Outlook
The IMF released its "World Economic Outlook" on April 14, 2026, trimming its global growth forecasts. Local experts are keeping a close eye on how this will play out for the export-heavy economy.
Central Bank Eyes July Rate Hike; Inflation Seen at 2.8–3.3%
Citi’s latest report predicts the central bank is likely to begin hiking interest rates in July. Analysts expect inflation to hit 2.8% to 3.3% by September, though they noted a prolonged closure of the Strait of Hormuz could push the hike back.
Won-Dollar Exchange Rate Lingers Near 1,500
The won-dollar exchange rate has been hovering around the 1,500 mark—the first time it’s hit or crossed this level since the 2008 global financial crisis. While experts don't see this as an immediate sign of a financial collapse, market anxiety is definitely on the rise.
Market Recovery Post-Mideast Tensions and US-Iran Truce
April 13 saw a complex mix of news, from Mideast geopolitical tensions and oil price volatility to a strong rebound in US markets and new support policies for small businesses. Locally, the market has been rallying since the two-week US-Iran truce was announced on the 8th.
Corporate News
Top 1,000 Listed Firms Report Record Profits
Last year, the operating profit of the top 1,000 listed companies hit nearly 190 trillion won—the highest level since 2000. The "1 Trillion Won Operating Profit Club" also saw its largest number of members to date, thanks largely to a rebound in semiconductors and major exports.
FSS to Overhaul Pharma/Biotech Disclosure Rules
The Financial Supervisory Service (FSS) is planning a major overhaul of disclosure rules for pharma and biotech firms to better protect investors. The move follows concerns over the gap between valuation expectations—often fueled by potential license-out deals—and actual cash flow. The FSS is looking to prevent scenarios similar to the recent issue involving Samchundang Pharm, which is expected to affect the local ETF market.
Today’s IR Schedule: Nongshim, Global Tax Free, TLB, and More
IR sessions scheduled for April 15 include presentations from Dongbang Medical (value enhancement), TLB (details on rights offering), and ISU Specialty Chemical (materials/industrial sectors).
Market Impact Analysis
① KOSPI Eyes 6,000 Points: The "Double Listing" Illusion
Recent analysis suggests that as the KOSPI pushes toward 6,000 points, "optical illusions" caused by double-listed companies may be artificially inflating the index, making it harder to gauge the true state of market recovery.
② Recovery Speed Following Mideast Volatility
After experiencing some of the sharpest post-war fluctuations globally, all eyes are on how quickly the market can regain its footing. With the US-Iran truce now in place, the market is already showing strong gains, with investors betting on a possible return to previous highs.
③ A Triple Whammy: Growth Downgrades, Weak Currency, and Rate Hikes
The market is currently facing three major hurdles: the IMF’s lowered growth outlook, a weak currency nearing 1,500 to the dollar, and the prospect of a July rate hike. However, with corporate fundamentals at record-high profit levels, there’s plenty of debate about which direction the index will head next.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
